Though it’s hard to say exactly what the future holds for mass GLP-1 compounding, the pressure is mounting from multiple angles in the U.S. | Eli Lilly—which has already staged multiple efforts in ...
Eli Lilly and Co on Thursday issued a public warning about potential safety risks linked to compounded tirzepatide products that are mixed with vitamin B12. The company said internal testing detected ...
The impurity discovery highlights the risks of mixing untested additives with complex molecules like tirzepatide without rigorous testing.
FDA’s recent focus on potentially harmful color additives in food products has expanded to the pharmaceutical sector. In May 2025, FDA issued a draft guidance titled Replacing Color Additives in ...
Color additives used in drug products must conform to FDA regulations and be properly listed and approved for the specific use. While a qualitative or quantitative change in inactive ingredients is ...
Add Yahoo as a preferred source to see more of our stories on Google. Xylazine, called by its street name “Tranq” is spreading through the illegal drug market in the United States. (Markus Spiske via ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results